Medtronic to Participate in the Piper Jaffray Post-EuroPCR Summit -- Angioplasty.Org

Home » StentCenter » Stent News » May 18, 2009

Medtronic to Participate in the Piper Jaffray Post-EuroPCR Summit

related stories:
Drug-Eluting Stent Center

external sites:
Medtronic, Inc.

May 18, 2009 -- Minneapolis -- Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Piper Jaffray PCR Post-Op Summit on Friday, May 22, 2009, in London.

Scott Ward, President,
CardioVascular Medtronic

Scott Ward, president of the CardioVascular business and senior vice president at Medtronic, will speak to the attendees of the conference at 8 a.m. British Summer Time (2 a.m. Central Daylight Time). Ward will provide remarks highlighting Medtronic’s activities and product news from the EuroPCR conference.

A live audio webcast of the presentation will be available to all interested parties at Medtronic’s Investor Relations website at http://www.medtronic.com.

About Medtronic
Medtronic, Inc., headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.

Source: Medtronic, Inc.

(Disclaimer: external links to news, press releases and other timely information sources are provided as a service by Angioplasty.Org, which is not responsible for the content found on any external sites. Items marked with a ($$) indicate that the external site normally restricts viewing to paid subscribers. Other sites may require free registration.

Angioplasty.Org Home • PatientCenter

send comments & suggestions to "info at angioplasty dot org"
read Terms of Use and Privacy statement

Angioplasty.Org is an independent educational health site
The StentCenter on Angioplasty.Org is supported by
Medtronic, Inc.
Unless otherwise noted, all content, including text, photos and video
© Copyright Venture Digital LLC 1996-2010